Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Baricitinib was effective in treating both early and late onset alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Many patients on new leukemia drugs had mild to moderate skin reactions.